Frequent small sips work better than occasional gulps, especially because gastric emptying is slower on treatment
GLP-1 medications are FDA-approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27-29.9) with at least one weight-related comorbidity
compounded preparations of those active ingredients are regulated differently
Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist that showed up to 24.2% weight loss in phase 2 trials at 48 weeks, potentially exceeding both CagriSema and tirzepatide
Because you are drawing the wrong amount of liquid from your vial, and every incorrect draw costs you money, results, and time you cannot get back
As with any medication, staying informed about your medical history and any possible side effects is crucial for maintaining overall health and well-being